Novacea merges with Transcept Pharmaceuticals - MarketLine Financial Deals

Novacea merges with Transcept Pharmaceuticals

Novacea merges with Transcept Pharmaceuticals - MarketLine Financial Deals
Novacea merges with Transcept Pharmaceuticals
Published Jan 30, 2009
3 pages — Published Jan 30, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Novacea, Inc., a biopharmaceutical company focused on in-licensing, developing, and commercializing therapies for the treatment of cancer, has merged with Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company.

  
Source:
Document ID
MA01424_090203
Country
Ticker
TSPT=US
Ticker
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Novacea merges with Transcept Pharmaceuticals" Jan 30, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novacea-merges-with-Transcept-Pharmaceuticals-2052-1356>
  
APA:
MarketLine Financial Deals. (2009). Novacea merges with Transcept Pharmaceuticals Jan 30, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novacea-merges-with-Transcept-Pharmaceuticals-2052-1356>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.